Association between Painful Physical Symptoms and Clinical Outcomes in Korean Patients with Major Depressive Disorder:A Three-Month Observational Study

被引:10
|
作者
Lee, Min Soo [2 ]
Yum, Sun Young [1 ]
Hong, Jin Pyo [3 ]
Yoon, Se Chang [4 ]
Noh, Jai Sung [5 ]
Lee, Kwang Hun [6 ]
Kim, Jung Ki [7 ]
Lee, Sang Yeol [8 ]
Singh, Pritibha [9 ]
Treuer, Tamas [10 ]
Reed, Victoria [9 ]
Raskin, Joel [11 ]
机构
[1] Eli Lilly & Co, Seoul, South Korea
[2] Korea Univ, Coll Med, Dept Psychiat, Seoul 136705, South Korea
[3] Univ Ulsan, Asan Med Ctr, Dept Psychiat, Seoul, South Korea
[4] Sungkyunkwan Univ, Samsung Med Ctr, Dept Neuropsychiat, Seoul, South Korea
[5] Ajou Univ, Sch Med, Dept Psychiat, Suwon 441749, South Korea
[6] Donguk Univ, Kyoungju Med Ctr, Dept Neuropsychiat, Gyeongju, South Korea
[7] Pusan Merinol Med Ctr, Dept Neuropsychiat, Pusan, South Korea
[8] Wonkwang Univ Hosp, Dept Psychiat, Iksan, South Korea
[9] Eli Lilly & Co, Intercontinental Informat Sci, Sydney, NSW, Australia
[10] Eli Lilly & Co, Budapest, Hungary
[11] Eli Lilly & Co, Lilly Res Labs, Toronto, ON, Canada
关键词
Pain; Depressive disorder; Major; Korea; Quality of life; Depression; Culture; TENSION-TYPE HEADACHE; PSYCHIATRIC-DISORDERS; SOMATIC SYMPTOMS; IMMIGRANT WOMEN; HWA-BYUNG; AMERICAN; EPIDEMIOLOGY; SOMATIZATION; PREVALENCE; DULOXETINE;
D O I
10.4306/pi.2009.6.4.255
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective This paper aims to examine the association between painful physical symptoms (ITS) and major depressive disorder (MDD) in a naturalistic clinical practice setting within a Korean population. Methods Patients with acute MDD that joined a multicountry, observational, three-month Study in six Asian countries and regions ere classified as PPS+ (mean score >= 2) and PPS- (mean score <2) using the modified Somatic Symptom Inventory. In this analysis, we report, the results from the Korea,, subset, where depression severity was assessed using the Clinical Global Impression of Severity (CGI-S) scale and 17-item Hamilton Depression Rating Scale (HAMD(17)) Pain severity was measured using a Visual analogue scale (VAS), while the EuroQoL (EQ-5D) assessed patient well-being. Results Of 198 patients, 45.96% (91/198) of patients were classified as PPS+ of which, 78.02% (71/91) were women. PPS+ patients had significantly more severe depression at baseline {CGI-S score, mean [standard deviation (SD)], PPS+: 5.09 [0.79]; PPS-: 4.63 [0.76]; p<0.001; HAMD(17) total score, mean [SD], PPS+: 24.34 [5.24]; PPS-: 20.76 [5.12]; p<0.001} and poorer quality of life [EQ-5D overall health state, mean (SD), PPS+: 39.37 (20.52); PPS-: 51.27 [20.78]; p<0.001] than PPS- patients. Both groups improved significantly (p<0.001) in depression and pain severity outcomes, as well as quality of life by end-point, but 110 significant within-group baseline-to-endpoint change wase observed. Conclusion The frequency of PPS was common in Korean patients with MDD and was, associated with more severe depression, poorer quality of life, and a trend towards poorer clinical outcome. Psychiatry Invest 2009;6:255-263
引用
收藏
页码:255 / 263
页数:9
相关论文
共 50 条
  • [21] Differences in depressive symptoms between Korean and American outpatients with major depressive disorder
    Jeon, Hong Jin
    Walker, Rosemary S.
    Inamori, Aya
    Hong, Jin Pyo
    Cho, Maeng Je
    Baer, Lee
    Clain, Alisabet
    Fava, Maurizio
    Mischoulon, David
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2014, 29 (03) : 150 - 156
  • [22] Predictors of depressive symptoms in patients with stroke - a three-month follow-up
    Sienkiewicz-Jarosz, Halina
    Milewska, Danuta
    Bochynska, Anna
    Chelmniak, Adrianna
    Dworek, Natalia
    Kasprzyk, Katarzyna
    Galecka, Katarzyna
    Szczepanska-Szerej, Anna
    Chwojnicki, Kamil
    Zyluk, Beata
    Slowik, Agnieszka
    Ryglewicz, Danuta
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2010, 44 (01) : 13 - 20
  • [23] ASSOCIATION BETWEEN MAJOR DEPRESSIVE DISORDER AND PHYSICAL ILLNESS
    MOLDIN, SO
    SCHEFTNER, WA
    RICE, JP
    NELSON, E
    KNESEVICH, MA
    AKISKAL, H
    PSYCHOLOGICAL MEDICINE, 1993, 23 (03) : 755 - 761
  • [24] The efficacy of duloxetine (60 mg qd) in the treatment of painful physical symptoms in patients with major depressive disorder
    Wohlreich, MM
    Mallinckrodt, CH
    Lu, Y
    Detke, MJ
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2003, 55 (02) : 157 - 157
  • [25] Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder
    Zhao, Rui
    Zhang, Zhiqiang
    Li, Hong
    Lv, Dongsheng
    Wang, Ping
    Zhao, Hongyi
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2024, (206):
  • [26] Impact of painful physical symptoms on first-episode major depressive disorder in adults with subthreshold depressive symptoms: A prospective cohort study
    Li, Xiuwen
    Zhang, Huimin
    Wu, Keying
    Fan, Beifang
    Guo, Lan
    Liao, Yuhua
    McIntyre, Roger S.
    Wang, Wanxin
    Liu, Yifeng
    Shi, Jingman
    Chen, Yan
    Shen, Manjun
    Wang, Hongqiong
    Li, Lingjiang
    Han, Xue
    Lu, Ciyong
    GENERAL HOSPITAL PSYCHIATRY, 2024, 86 : 1 - 9
  • [27] Duloxetine versus placebo in the treatment of major depressive disorder and associated painful physical symptoms: a replication study
    Gaynor, Paula J.
    Gopal, Murali
    Zheng, Wei
    Martinez, James M.
    Robinson, Michael J.
    Hann, Danette
    Marangell, Lauren B.
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (10) : 1859 - 1867
  • [28] Anxiety symptoms in working patients with major depressive disorder: associations with clinical and treatment outcomes in the AtWoRC study
    Chokka, P.
    Ge, H.
    Bougie, J.
    Clerzius, G.
    Ettrup, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S139 - S139
  • [29] Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapy
    Kuga, Atsushi
    Otsubo, Tempei
    Tsuji, Toshinaga
    Hayashi, Shinji
    Imagawa, Hideyuki
    Fujikoshi, Shinji
    Escobar, Rodrigo
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2019, 15 : 809 - 817
  • [30] Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder
    Brannan, SK
    Mallinckrodt, CH
    Brown, EB
    Wohlreich, MM
    Watkin, JG
    Schatzberg, AF
    JOURNAL OF PSYCHIATRIC RESEARCH, 2005, 39 (01) : 43 - 53